These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 10078023)
1. [Hepatitis C virus infection and cardiomyopathy]. Matsumori A Nihon Rinsho; 1999 Feb; 57(2):455-63. PubMed ID: 10078023 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Matsumori A; Ohashi N; Hasegawa K; Sasayama S; Eto T; Imaizumi T; Izumi T; Kawamura K; Kawana M; Kimura A; Kitabatake A; Matsuzaki M; Nagai R; Tanaka H; Hiroe M; Hori M; Inoko H; Seko Y; Sekiguchi M; Shimotohno K; Sugishita Y; Takeda N; Takihara K; Tanaka M; Yokoyama M Jpn Circ J; 1998 May; 62(5):389-91. PubMed ID: 9626910 [TBL] [Abstract][Full Text] [Related]
3. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus and cardiomyopathy. Matsumori A Herz; 2000 May; 25(3):249-54. PubMed ID: 10904847 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection and cardiomyopathies. Matsumori A Circ Res; 2005 Feb; 96(2):144-7. PubMed ID: 15692092 [No Abstract] [Full Text] [Related]
6. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
7. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Radkowski M; Gallegos-Orozco JF; Jablonska J; Colby TV; Walewska-Zielecka B; Kubicka J; Wilkinson J; Adair D; Rakela J; Laskus T Hepatology; 2005 Jan; 41(1):106-14. PubMed ID: 15619235 [TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver]. Hige S Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730 [TBL] [Abstract][Full Text] [Related]
9. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of HCV replication in patients with chronic hepatitis C during interferon and ribavirin combined therapy. Mazurek U; Jurzak M; Gola J; Mazur W; Szuścik T; Krysiak R; Gonciarz Z; Wilczok T Med Sci Monit; 2001 May; 7 Suppl 1():236-40. PubMed ID: 12211727 [TBL] [Abstract][Full Text] [Related]
13. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment. Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283 [TBL] [Abstract][Full Text] [Related]
14. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis. Watkins-Riedel T; Ferenci P; Steindl-Munda P; Gschwantler M; Mueller C; Woegerbauer M Clin Infect Dis; 2004 Dec; 39(12):1754-60. PubMed ID: 15578395 [TBL] [Abstract][Full Text] [Related]
15. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin. Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537 [TBL] [Abstract][Full Text] [Related]
16. Acute hepatitis C: prevention and treatment. Ozaras R; Tahan V Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247 [TBL] [Abstract][Full Text] [Related]
17. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715 [TBL] [Abstract][Full Text] [Related]
18. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C]. Takeuchi M; Kaneko S; Unoura M; Kobayashi K Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912 [No Abstract] [Full Text] [Related]
19. Hepatitis C virus infection and cryoglobulinaemia. Lunel F; Musset L Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994 [TBL] [Abstract][Full Text] [Related]
20. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]